cholangiocarcinoma

Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink
Zhiwei Liu, Rotana Alsaggaf, Katherine A McGlynn, Lesley A Anderson, Huei-Ting Tsai, Bin Zhu, Yue Zhu, Sam M Mbulaiteye, Shahinaz M Gadalla, Jill Koshiol

Gut Aug 2019, 68 (8) 1458-1464; DOI: 10.1136/gutjnl-2018-317504
Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures
Aatur D Singhi, Marina N Nikiforova, Jennifer Chennat, Georgios I Papachristou, Asif Khalid, Mordechai Rabinovitz, Rohit Das, Savreet Sarkaria, M Samir Ayasso, Abigail I Wald, Sara E Monaco, Michael Nalesnik, N Paul Ohori, David Geller, Allan Tsung, Amer H Zureikat, Herbert Zeh, J Wallis Marsh, Melissa Hogg, Kenneth Lee, David L Bartlett, James F Pingpank, Abhinav Humar, Nathan Bahary, Anil K Dasyam, Randall Brand, Kenneth E Fasanella, Kevin McGrath, Adam Slivka

Gut Apr 2019, gutjnl-2018-317817; DOI: 10.1136/gutjnl-2018-317817
Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
Steven P O’Hara, Tom H Karlsen, Nicholas F LaRusso

Gut Nov 2017, 66 (11) 1873-1877; DOI: 10.1136/gutjnl-2017-314249
PTH-012 Preliminary results of a novel temperature controlled endo luminal radio-frequency ablation (elra) electrode for treatment of blocked biliary stents in patients with inoperable pancreaticobiliary cancers
M Nayar, K Oppong, N Bekkali, J Leeds

Gut Jul 2017, 66 (Suppl 2) A210; DOI: 10.1136/gutjnl-2017-314472.409
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers
Pietro Carotenuto, Matteo Fassan, Rosantony Pandolfo, Andrea Lampis, Caterina Vicentini, Luciano Cascione, Viola Paulus-Hock, Luke Boulter, Rachel Guest, Luca Quagliata, Jens Claus Hahne, Rachel Ridgway, Tam Jamieson, Dimitris Athineos, Angelo Veronese, Rosa Visone, Claudio Murgia, Giulia Ferrari, Vincenza Guzzardo, Thomas Ronald Jeffry Evans, Martin MacLeod, Gui Ji Feng, Trevor Dale, Massimo Negrini, Stuart J Forbes, Luigi Terracciano, Aldo Scarpa, Tushar Patel, Nicola Valeri, Paul Workman, Owen Sansom, Chiara Braconi

Gut Jul 2017, 66 (7) 1268-1277; DOI: 10.1136/gutjnl-2016-312278
Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis
Sebastian Torben Jendrek, Daniel Gotthardt, Thomas Nitzsche, Laila Widmann, Tobias Korf, Maike Anna Michaels, Karl-Heinz Weiss, Evaggelia Liaskou, Mette Vesterhus, Tom Hemming Karlsen, Swantje Mindorf, Peter Schemmer, Florian Bär, Bianca Teegen, Torsten Schröder, Marc Ehlers, Christoph Matthias Hammers, Lars Komorowski, Hendrik Lehnert, Klaus Fellermann, Stefanie Derer, Johannes Roksund Hov, Christian Sina

Gut Jan 2017, 66 (1) 137-144; DOI: 10.1136/gutjnl-2016-311739
Anti-GP2 IgA: a biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?
Sumera Rizvi, Ju Dong Yang, Gregory J Gores

Gut Jan 2017, 66 (1) 4-5; DOI: 10.1136/gutjnl-2016-312492
Targeting TGR5 in cholangiocyte proliferation: default topic
Cecília M P Rodrigues, Han Moshage

Gut Mar 2016, 65 (3) 369-370; DOI: 10.1136/gutjnl-2015-310812
TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro
Maria Reich, Kathleen Deutschmann, Annika Sommerfeld, Caroline Klindt, Stefanie Kluge, Ralf Kubitz, Christoph Ullmer, Wolfram T Knoefel, Diran Herebian, Ertan Mayatepek, Dieter Häussinger, Verena Keitel

Gut Mar 2016, 65 (3) 487-501; DOI: 10.1136/gutjnl-2015-309458
GI highlights from the literature
Mairi H McLean

Gut Jun 2015, 64 (6) 1001-1002; DOI: 10.1136/gutjnl-2015-309616

Main menu

cholangiocarcinoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

cholangiocarcinoma

Pages